Subscribe Register Login

Thursday, December 18, 2014, 7:33 p.m.
Top Picks - Mobile App

Oral arguments set over J&J appeal of $1 billion Risperdal fine

By The Associated Press

This article was published January 13, 2014 at 12:27 p.m.

LITTLE ROCK — The Arkansas Supreme Court has scheduled oral arguments in Johnson & Johnson's request to overturn a verdict and $1.2 billion fine over the marketing of the antipsychotic drug Risperdal.

Oral arguments are set for Feb. 27 in Little Rock for the appeal from Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. Attorney General Dustin McDaniel successfully sued the companies, claiming they downplayed and hid risks associated with taking Risperdal.

In 2012, a Pulaski County judge fined the two companies $5,000 for each of 240,000 Risperdal prescriptions the state Medicaid program paid for during a 3½-year period.

In a separate case, Johnson & Johnson agreed to a $2.2 billion settlement with the U.S. Department of Justice in November over allegations that it promoted three drugs, including Risperdal, for off-label uses.

Comments on: Oral arguments set over J&J appeal of $1 billion Risperdal fine

To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Read our Terms of Use policy.

Subscribe Register Login

You must login to make comments.

TOP JOBS

Search 737 jobs >

Top Picks - Mobile App
Arkansas Online